138 related articles for article (PubMed ID: 26681550)
1. Zerumbone Suppresses Osteopontin-Induced Cell Invasion Through Inhibiting the FAK/AKT/ROCK Pathway in Human Non-Small Cell Lung Cancer A549 Cells.
Kang CG; Lee HJ; Kim SH; Lee EO
J Nat Prod; 2016 Jan; 79(1):156-60. PubMed ID: 26681550
[TBL] [Abstract][Full Text] [Related]
2. Rho-associated kinase signaling is required for osteopontin-induced cell invasion through inactivating cofilin in human non-small cell lung cancer cell lines.
Kang CG; Han HJ; Lee HJ; Kim SH; Lee EO
Bioorg Med Chem Lett; 2015 May; 25(9):1956-60. PubMed ID: 25817589
[TBL] [Abstract][Full Text] [Related]
3. Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.
Kang CG; Im E; Lee HJ; Lee EO
Bioorg Med Chem Lett; 2017 May; 27(9):1914-1918. PubMed ID: 28359791
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin increases lung cancer cells migration via activation of the alphavbeta3 integrin/FAK/Akt and NF-kappaB-dependent pathway.
Fong YC; Liu SC; Huang CY; Li TM; Hsu SF; Kao ST; Tsai FJ; Chen WC; Chen CY; Tang CH
Lung Cancer; 2009 Jun; 64(3):263-70. PubMed ID: 18996613
[TBL] [Abstract][Full Text] [Related]
5. ROCK1 promotes migration and invasion of non‑small‑cell lung cancer cells through the PTEN/PI3K/FAK pathway.
Hu C; Zhou H; Liu Y; Huang J; Liu W; Zhang Q; Tang Q; Sheng F; Li G; Zhang R
Int J Oncol; 2019 Oct; 55(4):833-844. PubMed ID: 31485605
[TBL] [Abstract][Full Text] [Related]
6. OPN promotes the aggressiveness of non-small-cell lung cancer cells through the activation of the RON tyrosine kinase.
Hao C; Cui Y; Chang S; Huang J; Birkin E; Hu M; Zhi X; Li W; Zhang L; Cheng S; Jiang WG
Sci Rep; 2019 Dec; 9(1):18101. PubMed ID: 31792339
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of ethanol extract of Ocimum sanctum on osteopontin mediated metastasis of NCI-H460 non-small cell lung cancer cells.
Kwak TK; Sohn EJ; Kim S; Won G; Choi JU; Jeong K; Jeong M; Kwon OS; Kim SH
BMC Complement Altern Med; 2014 Oct; 14():419. PubMed ID: 25345853
[TBL] [Abstract][Full Text] [Related]
8. Zerumbone suppresses IKKα, Akt, and FOXO1 activation, resulting in apoptosis of GBM 8401 cells.
Weng HY; Hsu MJ; Wang CC; Chen BC; Hong CY; Chen MC; Chiu WT; Lin CH
J Biomed Sci; 2012 Oct; 19(1):86. PubMed ID: 23035900
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin mediates tumorigenic transformation of a preneoplastic murine cell line by suppressing anoikis: an Arg-Gly-Asp-dependent-focal adhesion kinase-caspase-8 axis.
Hsieh YH; van der Heyde H; Oh ES; Guan JL; Chang PL
Mol Carcinog; 2015 May; 54(5):379-92. PubMed ID: 24249517
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin knockdown suppresses non-small cell lung cancer cell invasion and metastasis.
Sun BS; You J; Li Y; Zhang ZF; Wang CL
Chin Med J (Engl); 2013; 126(9):1683-8. PubMed ID: 23652051
[TBL] [Abstract][Full Text] [Related]
11. Activation of RhoA and FAK induces ERK-mediated osteopontin expression in mechanical force-subjected periodontal ligament fibroblasts.
Hong SY; Jeon YM; Lee HJ; Kim JG; Baek JA; Lee JC
Mol Cell Biochem; 2010 Feb; 335(1-2):263-72. PubMed ID: 19798549
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells.
Das R; Mahabeleshwar GH; Kundu GC
J Biol Chem; 2003 Aug; 278(31):28593-606. PubMed ID: 12771144
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.
Das R; Philip S; Mahabeleshwar GH; Bulbule A; Kundu GC
IUBMB Life; 2005 Jun; 57(6):441-7. PubMed ID: 16012053
[TBL] [Abstract][Full Text] [Related]
14. Blockade of integrin beta3-FAK signaling pathway activated by osteopontin inhibits neointimal formation after balloon injury.
Han M; Wen JK; Zheng B; Liu Z; Chen Y
Cardiovasc Pathol; 2007; 16(5):283-90. PubMed ID: 17868879
[TBL] [Abstract][Full Text] [Related]
15. PLEKHH2 binds β-arrestin1 through its FERM domain, activates FAK/PI3K/AKT phosphorylation, and promotes the malignant phenotype of non-small cell lung cancer.
Wang R; Wang S; Li Z; Luo Y; Zhao Y; Han Q; Rong XZ; Guo YX; Liu Y
Cell Death Dis; 2022 Oct; 13(10):858. PubMed ID: 36209201
[TBL] [Abstract][Full Text] [Related]
16. Anticancer effects of α-Bisabolol in human non-small cell lung carcinoma cells are mediated via apoptosis induction, cell cycle arrest, inhibition of cell migration and invasion and upregulation of P13K/AKT signalling pathway.
Wu S; Peng L; Sang H; Ping Li Q; Cheng S
J BUON; 2018; 23(5):1407-1412. PubMed ID: 30570866
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-mesenchymal transition is associated with osteopontin-induced EGFR‑TKI resistance in EGFR mutant non-small cell lung cancer.
Chen J; Shi L; Qian Y; Jin Y; Dong N; Chen C; Wang B
J Thorac Dis; 2023 Jun; 15(6):3359-3371. PubMed ID: 37426126
[TBL] [Abstract][Full Text] [Related]
18. DADS downregulates the Rac1-ROCK1/PAK1-LIMK1-ADF/cofilin signaling pathway, inhibiting cell migration and invasion.
Zhou Y; Su J; Shi L; Liao Q; Su Q
Oncol Rep; 2013 Feb; 29(2):605-12. PubMed ID: 23233092
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin stimulates vascular smooth muscle cell migration by inducing FAK phosphorylation and ILK dephosphorylation.
Li JJ; Han M; Wen JK; Li AY
Biochem Biophys Res Commun; 2007 Apr; 356(1):13-9. PubMed ID: 17336930
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-138 inhibits migration and invasion of non-small cell lung cancer cells by targeting LIMK1.
Tan Y; Hu H; Tan W; Jin L; Liu J; Zhou H
Mol Med Rep; 2016 Nov; 14(5):4422-4428. PubMed ID: 27665963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]